Latest filing published 26 Jul 2018 for Provention Bio, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -51.0%Entry US$25.50 · Close at T+365 US$12.50
- -52.5%Entry US$84.70 · Close at T+365 US$40.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter A. Appel: trading record in brief
This profile gathers the share dealings of Peter A. Appel across 4 companies, led by Arch Capital Group Ltd., Ideal Power Inc. and Provention Bio, Inc. We count 14 filings; the first trade dates from 16 February 2006 and the latest from 19 July 2018.
The open-market side counts 4 purchases for €6.2M alongside 2 sales for €7.8M. The net balance comes to €1.6M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 6 option exercises. In 2018 alone, the filings show 1 purchase and no sales.
The median purchase comes to €1.4M. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 26 July 2018, reports a transaction in Provention Bio, Inc. The latest purchase dates back some time: it was published 3,028 days ago, on 26 July 2018. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter A. Appel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,200,000 sharesCommon Stock, par value $0.0001 per shareSEC:0001140361-18-033671:0
- 750,000 shares@ US$4.00100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001140361-18-033671:1Canonical exit: 17 Oct 2018 (T+90)
- 394,400 shares@ US$2.54100.0% of flowCommon StockSEC:0001144204-17-012974:0Canonical exit: 1 Jun 2017 (T+90)
- 335,000 shares@ US$2.985100.0% of flowCommon StockSEC:0001104659-16-114356:0Canonical exit: 24 Jul 2016 (T+90)
- 258,000 shares@ US$7.75Common StockSEC:0001144204-15-032685:0Canonical exit: 13 Aug 2015 (T+90)
- 580,777 shares@ US$3.48Common StockSEC:0001415889-13-002487:0
- 34,153 shares@ US$23.00Common Shares, $.01 par value per shareSEC:0001179110-06-004466:0
- 58,344 shares@ US$22.44Common Shares, $.01 par value per shareSEC:0001179110-06-004466:1
- 4,456 shares@ US$22.44Common Shares, $.01 par value per shareSEC:0001179110-06-004466:2
- 39,500 shares@ US$17.63Common Shares, $.01 par value per shareSEC:0001179110-06-004466:3
- 136,453 shares@ US$56.25Common Shares, $.01 par value per shareSEC:0001179110-06-004466:4
- 25,000 shares@ US$21.00Common Shares, $.01 par value per shareSEC:0001179110-06-004129:0
- 4,347 shares@ US$23.00Common Shares, $.01 par value per shareSEC:0001179110-06-004129:1
- 29,347 shares@ US$55.70Common Shares, $.01 par value per shareSEC:0001179110-06-004129:2
14 of 14 declarations
